Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 2/20 | 0.66 |
| ▸ | ATM | Q13315 | 1/20 | 0.66 |
| ▸ | SIRT2 | Q8IXJ6 | 1/20 | 0.65 |
| ▸ | NOTUM | Q6P988 | 2/20 | 0.64 |
| ▸ | L3MBTL1 | Q9Y468 | 5/20 | 0.63 |
| ▸ | MAPT | P10636 | 5/20 | 0.63 |
| ▸ | NPC1 | O15118 | 4/20 | 0.63 |
| ▸ | RAB9A | P51151 | 4/20 | 0.63 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.62 |
| ▸ | TSHR | P16473 | 3/20 | 0.62 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.62 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.62 |
| ▸ | HTT | P42858 | 2/20 | 0.62 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.62 |
| ▸ | MEN1 | O00255 | 1/20 | 0.62 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.62 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.62 |
| ▸ | CASP3 | P42574 | 1/20 | 0.60 |
| ▸ | SENP8 | Q96LD8 | 1/20 | 0.60 |
| ▸ | SENP7 | Q9BQF6 | 1/20 | 0.60 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17513948 | 0.84 | SIRT2 (0.65) | LMNAATMSIRT2NOTUML3MBTL1 | |
| SCHEMBL1220782 | 0.84 | SMN1; SMN2 (0.66) | LMNAATMSIRT2L3MBTL1MAPT | |
| SCHEMBL14788168 | 0.84 | SIRT2 (0.74) | LMNAATMSIRT2L3MBTL1MAPT | |
| SCHEMBL7952282 | 0.83 | SIRT2 (0.72) | LMNAATMSIRT2L3MBTL1MAPT | |
| SCHEMBL6325229 | 0.82 | LMNA (0.76) | LMNAATMSIRT2L3MBTL1MAPT | |
| SCHEMBL6527881 | 0.81 | NOTUM (0.70) | LMNAATMNOTUML3MBTL1MAPT | |
| SCHEMBL7148635 | 0.81 | SIRT2 (0.70) | LMNAATMSIRT2L3MBTL1MAPT | |
| SCHEMBL27035148 | 0.81 | ALDH1A1 (0.65) | LMNAATMSIRT2L3MBTL1MAPT | |
| SCHEMBL15133520 | 0.81 | KMT2A (0.63) | LMNAATMSIRT2L3MBTL1MAPT | |
| SCHEMBL1567346 | 0.80 | LMNA (1.00) | LMNAATMSIRT2L3MBTL1MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250091999-A1 | [3-(4-METHOXYPHENYL)-1,2,4-OXADIAZOL-5-YL]METHANOL AS AN ANTITUMOR AND ANTIMICROBIAL COMPOUND | UNIV KING FAISAL (SA) | 2025-03-20 | — | — | US | claimed |
| US-12180172-B1 | [3-(4-Methoxyphenyl)-1,2,4-oxadiazol-5-yl]methanol as an antitumor and antimicrobial compound | King Faisal University (SA) | 2024-12-31 | — | — | US | claimed |
| US-20250091999-A1 | [3-(4-METHOXYPHENYL)-1,2,4-OXADIAZOL-5-YL]METHANOL AS AN ANTITUMOR AND ANTIMICROBIAL COMPOUND | UNIV KING FAISAL (SA) | 2025-03-20 | — | — | US | disclosed |
| US-20250091999-A1 | [3-(4-METHOXYPHENYL)-1,2,4-OXADIAZOL-5-YL]METHANOL AS AN ANTITUMOR AND ANTIMICROBIAL COMPOUND | UNIV KING FAISAL (SA) | 2025-03-20 | — | — | US | disclosed |
| US-20250091999-A1 | [3-(4-METHOXYPHENYL)-1,2,4-OXADIAZOL-5-YL]METHANOL AS AN ANTITUMOR AND ANTIMICROBIAL COMPOUND | UNIV KING FAISAL (SA) | 2025-03-20 | — | — | US | disclosed |
| US-12180172-B1 | [3-(4-Methoxyphenyl)-1,2,4-oxadiazol-5-yl]methanol as an antitumor and antimicrobial compound | King Faisal University (SA) | 2024-12-31 | — | — | US | disclosed |
| US-12180172-B1 | [3-(4-Methoxyphenyl)-1,2,4-oxadiazol-5-yl]methanol as an antitumor and antimicrobial compound | King Faisal University (SA) | 2024-12-31 | — | — | US | disclosed |
| US-12180172-B1 | [3-(4-Methoxyphenyl)-1,2,4-oxadiazol-5-yl]methanol as an antitumor and antimicrobial compound | King Faisal University (SA) | 2024-12-31 | — | — | US | disclosed |
| WO-1997003967-A1 | SUBSTITUTED AROMATIC COMPOUNDS AND THEIR PHARMACEUTICAL USE | RHONE-POULENC RORER LIMITED (GB) | 1997-02-06 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250091999-A1 | [3-(4-METHOXYPHENYL)-1,2,4-OXADIAZOL-5-YL]METHANOL AS AN ANTITUMOR AND ANTIMICROBIAL COMPOUND | OXA1L, MCL1, CASP3 | LMNA 4266/4885ATM 1674/4885SIRT2 1993/4885 |
| US-12180172-B1 | [3-(4-Methoxyphenyl)-1,2,4-oxadiazol-5-yl]methanol as an antitumor and antimicrobial compound | OXA1L, MCL1, CASP3 | LMNA 4266/4885ATM 1674/4885SIRT2 1993/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.